Jaguar Health Inc (JAGX)

Add to Watchlists
Create an Alert
0.3201 -0.03  -9.78% NASDAQ Mar 20, 15:21 Delayed 2m USD
View Full Chart
JAGX Price Chart
View All Events

JAGX Events

Date Type Description
06/01/2018 Splits Ratio: 666667:10000000
View All Performance Charts

JAGX Total Returns Comparison


JAGX One Page Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Jaguar Health Inc is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products. The company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the marketplace from plants used traditionally in rainforest areas. Its Mytesi (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

JAGX Comparables


JAGX Excel Add-In Codes

  • Name: =YCI("JAGX","name")
  • Description: =YCI("JAGX","description")
  • Sector: =YCI("JAGX","sector")
  • Industry: =YCI("JAGX","industry")
  • Est. Current Fiscal Year End: =YCI("JAGX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.